 | • レポートコード：MRC2-11QY07913 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はムチン1のグローバル市場について調査・分析したレポートです。種類別（TG-4010、GO-2032c、ImMucin、BI-1361849、その他）市場規模、用途別（前立腺がん、乳がん、結腸がん、卵巣がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ムチン1の競争状況、市場シェア ・世界のムチン1市場：種類別市場規模 2015年-2020年（TG-4010、GO-2032c、ImMucin、BI-1361849、その他） ・世界のムチン1市場：種類別市場規模予測 2021年-2026年（TG-4010、GO-2032c、ImMucin、BI-1361849、その他） ・世界のムチン1市場：用途別市場規模 2015年-2020年（前立腺がん、乳がん、結腸がん、卵巣がん、その他） ・世界のムチン1市場：用途別市場規模予測 2021年-2026年（前立腺がん、乳がん、結腸がん、卵巣がん、その他） ・北米のムチン1市場分析：米国、カナダ ・ヨーロッパのムチン1市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのムチン1市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のムチン1市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのムチン1市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Akshaya Bio Inc、Bavarian Nordic A/S、Boehringer Ingelheim GmbH、Etubics Corp、GeoVax Labs Inc、Merck KGaA、Minerva Biotechnologies Corp、Transgene SA、Vaxil Bio Therapeutics Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Mucin 1 Market
The global Mucin 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Mucin 1 Scope and Market Size
Mucin 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mucin 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Mucin 1 market is segmented into
TG-4010
GO-2032c
ImMucin
BI-1361849
Others
Segment by Application, the Mucin 1 market is segmented into
Prostate Cancer
Breast Cancer
Colon Cancer
Ovarian Cancer
Others
Regional and Country-level Analysis
The Mucin 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Mucin 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Mucin 1 Market Share Analysis
Mucin 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Mucin 1 business, the date to enter into the Mucin 1 market, Mucin 1 product introduction, recent developments, etc.
The major vendors covered:
Akshaya Bio Inc
Bavarian Nordic A/S
Boehringer Ingelheim GmbH
Etubics Corp
GeoVax Labs Inc
Merck KGaA
Minerva Biotechnologies Corp
Transgene SA
Vaxil Bio Therapeutics Ltd
1 Study Coverage
1.1 Mucin 1 Product Introduction
1.2 Market Segments
1.3 Key Mucin 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Mucin 1 Market Size Growth Rate by Type
1.4.2 TG-4010
1.4.3 GO-2032c
1.4.4 ImMucin
1.4.5 BI-1361849
1.4.6 Others
1.5 Market by Application
1.5.1 Global Mucin 1 Market Size Growth Rate by Application
1.5.2 Prostate Cancer
1.5.3 Breast Cancer
1.5.4 Colon Cancer
1.5.5 Ovarian Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Mucin 1 Market Size, Estimates and Forecasts
2.1.1 Global Mucin 1 Revenue 2015-2026
2.1.2 Global Mucin 1 Sales 2015-2026
2.2 Global Mucin 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Mucin 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Mucin 1 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Mucin 1 Competitor Landscape by Players
3.1 Mucin 1 Sales by Manufacturers
3.1.1 Mucin 1 Sales by Manufacturers (2015-2020)
3.1.2 Mucin 1 Sales Market Share by Manufacturers (2015-2020)
3.2 Mucin 1 Revenue by Manufacturers
3.2.1 Mucin 1 Revenue by Manufacturers (2015-2020)
3.2.2 Mucin 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Mucin 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Mucin 1 Revenue in 2019
3.2.5 Global Mucin 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Mucin 1 Price by Manufacturers
3.4 Mucin 1 Manufacturing Base Distribution, Product Types
3.4.1 Mucin 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mucin 1 Product Type
3.4.3 Date of International Manufacturers Enter into Mucin 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mucin 1 Market Size by Type (2015-2020)
4.1.1 Global Mucin 1 Sales by Type (2015-2020)
4.1.2 Global Mucin 1 Revenue by Type (2015-2020)
4.1.3 Mucin 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Mucin 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global Mucin 1 Sales Forecast by Type (2021-2026)
4.2.2 Global Mucin 1 Revenue Forecast by Type (2021-2026)
4.2.3 Mucin 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Mucin 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Mucin 1 Market Size by Application (2015-2020)
5.1.1 Global Mucin 1 Sales by Application (2015-2020)
5.1.2 Global Mucin 1 Revenue by Application (2015-2020)
5.1.3 Mucin 1 Price by Application (2015-2020)
5.2 Mucin 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global Mucin 1 Sales Forecast by Application (2021-2026)
5.2.2 Global Mucin 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global Mucin 1 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Mucin 1 by Country
6.1.1 North America Mucin 1 Sales by Country
6.1.2 North America Mucin 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Mucin 1 Market Facts & Figures by Type
6.3 North America Mucin 1 Market Facts & Figures by Application
7 Europe
7.1 Europe Mucin 1 by Country
7.1.1 Europe Mucin 1 Sales by Country
7.1.2 Europe Mucin 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mucin 1 Market Facts & Figures by Type
7.3 Europe Mucin 1 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Mucin 1 by Region
8.1.1 Asia Pacific Mucin 1 Sales by Region
8.1.2 Asia Pacific Mucin 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Mucin 1 Market Facts & Figures by Type
8.3 Asia Pacific Mucin 1 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Mucin 1 by Country
9.1.1 Latin America Mucin 1 Sales by Country
9.1.2 Latin America Mucin 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Mucin 1 Market Facts & Figures by Type
9.3 Central & South America Mucin 1 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Mucin 1 by Country
10.1.1 Middle East and Africa Mucin 1 Sales by Country
10.1.2 Middle East and Africa Mucin 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Mucin 1 Market Facts & Figures by Type
10.3 Middle East and Africa Mucin 1 Market Facts & Figures by Application
11 Company Profiles
11.1 Akshaya Bio Inc
11.1.1 Akshaya Bio Inc Corporation Information
11.1.2 Akshaya Bio Inc Description and Business Overview
11.1.3 Akshaya Bio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akshaya Bio Inc Mucin 1 Products Offered
11.1.5 Akshaya Bio Inc Related Developments
11.2 Bavarian Nordic A/S
11.2.1 Bavarian Nordic A/S Corporation Information
11.2.2 Bavarian Nordic A/S Description and Business Overview
11.2.3 Bavarian Nordic A/S Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bavarian Nordic A/S Mucin 1 Products Offered
11.2.5 Bavarian Nordic A/S Related Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Corporation Information
11.3.2 Boehringer Ingelheim GmbH Description and Business Overview
11.3.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim GmbH Mucin 1 Products Offered
11.3.5 Boehringer Ingelheim GmbH Related Developments
11.4 Etubics Corp
11.4.1 Etubics Corp Corporation Information
11.4.2 Etubics Corp Description and Business Overview
11.4.3 Etubics Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Etubics Corp Mucin 1 Products Offered
11.4.5 Etubics Corp Related Developments
11.5 GeoVax Labs Inc
11.5.1 GeoVax Labs Inc Corporation Information
11.5.2 GeoVax Labs Inc Description and Business Overview
11.5.3 GeoVax Labs Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GeoVax Labs Inc Mucin 1 Products Offered
11.5.5 GeoVax Labs Inc Related Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Corporation Information
11.6.2 Merck KGaA Description and Business Overview
11.6.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck KGaA Mucin 1 Products Offered
11.6.5 Merck KGaA Related Developments
11.7 Minerva Biotechnologies Corp
11.7.1 Minerva Biotechnologies Corp Corporation Information
11.7.2 Minerva Biotechnologies Corp Description and Business Overview
11.7.3 Minerva Biotechnologies Corp Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Minerva Biotechnologies Corp Mucin 1 Products Offered
11.7.5 Minerva Biotechnologies Corp Related Developments
11.8 Transgene SA
11.8.1 Transgene SA Corporation Information
11.8.2 Transgene SA Description and Business Overview
11.8.3 Transgene SA Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Transgene SA Mucin 1 Products Offered
11.8.5 Transgene SA Related Developments
11.9 Vaxil Bio Therapeutics Ltd
11.9.1 Vaxil Bio Therapeutics Ltd Corporation Information
11.9.2 Vaxil Bio Therapeutics Ltd Description and Business Overview
11.9.3 Vaxil Bio Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Vaxil Bio Therapeutics Ltd Mucin 1 Products Offered
11.9.5 Vaxil Bio Therapeutics Ltd Related Developments
11.1 Akshaya Bio Inc
11.1.1 Akshaya Bio Inc Corporation Information
11.1.2 Akshaya Bio Inc Description and Business Overview
11.1.3 Akshaya Bio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akshaya Bio Inc Mucin 1 Products Offered
11.1.5 Akshaya Bio Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Mucin 1 Market Estimates and Projections by Region
12.1.1 Global Mucin 1 Sales Forecast by Regions 2021-2026
12.1.2 Global Mucin 1 Revenue Forecast by Regions 2021-2026
12.2 North America Mucin 1 Market Size Forecast (2021-2026)
12.2.1 North America: Mucin 1 Sales Forecast (2021-2026)
12.2.2 North America: Mucin 1 Revenue Forecast (2021-2026)
12.2.3 North America: Mucin 1 Market Size Forecast by Country (2021-2026)
12.3 Europe Mucin 1 Market Size Forecast (2021-2026)
12.3.1 Europe: Mucin 1 Sales Forecast (2021-2026)
12.3.2 Europe: Mucin 1 Revenue Forecast (2021-2026)
12.3.3 Europe: Mucin 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Mucin 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Mucin 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Mucin 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Mucin 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America Mucin 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: Mucin 1 Sales Forecast (2021-2026)
12.5.2 Latin America: Mucin 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: Mucin 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Mucin 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Mucin 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Mucin 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Mucin 1 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Mucin 1 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mucin 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Mucin 1 Market Segments
Table 2. Ranking of Global Top Mucin 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Mucin 1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of TG-4010
Table 5. Major Manufacturers of GO-2032c
Table 6. Major Manufacturers of ImMucin
Table 7. Major Manufacturers of BI-1361849
Table 8. Major Manufacturers of Others
Table 9. Global Mucin 1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Mucin 1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Mucin 1 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Mucin 1 Sales Market Share by Regions (2015-2020)
Table 13. Global Mucin 1 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Mucin 1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Mucin 1 Sales Share by Manufacturers (2015-2020)
Table 16. Global Mucin 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Mucin 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucin 1 as of 2019)
Table 18. Mucin 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Mucin 1 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Mucin 1 Price (2015-2020) (USD/Pcs)
Table 21. Mucin 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Mucin 1 Product Type
Table 23. Date of International Manufacturers Enter into Mucin 1 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Mucin 1 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Mucin 1 Sales Share by Type (2015-2020)
Table 27. Global Mucin 1 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Mucin 1 Revenue Share by Type (2015-2020)
Table 29. Mucin 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Mucin 1 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Mucin 1 Sales Share by Application (2015-2020)
Table 32. North America Mucin 1 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Mucin 1 Sales Market Share by Country (2015-2020)
Table 34. North America Mucin 1 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Mucin 1 Revenue Market Share by Country (2015-2020)
Table 36. North America Mucin 1 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Mucin 1 Sales Market Share by Type (2015-2020)
Table 38. North America Mucin 1 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Mucin 1 Sales Market Share by Application (2015-2020)
Table 40. Europe Mucin 1 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Mucin 1 Sales Market Share by Country (2015-2020)
Table 42. Europe Mucin 1 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Mucin 1 Revenue Market Share by Country (2015-2020)
Table 44. Europe Mucin 1 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Mucin 1 Sales Market Share by Type (2015-2020)
Table 46. Europe Mucin 1 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Mucin 1 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Mucin 1 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Mucin 1 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Mucin 1 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Mucin 1 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Mucin 1 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Mucin 1 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Mucin 1 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Mucin 1 Sales Market Share by Application (2015-2020)
Table 56. Latin America Mucin 1 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Mucin 1 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Mucin 1 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Mucin 1 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Mucin 1 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Mucin 1 Sales Market Share by Type (2015-2020)
Table 62. Latin America Mucin 1 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Mucin 1 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Mucin 1 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Mucin 1 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Mucin 1 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Mucin 1 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Mucin 1 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Mucin 1 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Mucin 1 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Mucin 1 Sales Market Share by Application (2015-2020)
Table 72. Akshaya Bio Inc Corporation Information
Table 73. Akshaya Bio Inc Description and Major Businesses
Table 74. Akshaya Bio Inc Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Akshaya Bio Inc Product
Table 76. Akshaya Bio Inc Recent Development
Table 77. Bavarian Nordic A/S Corporation Information
Table 78. Bavarian Nordic A/S Description and Major Businesses
Table 79. Bavarian Nordic A/S Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bavarian Nordic A/S Product
Table 81. Bavarian Nordic A/S Recent Development
Table 82. Boehringer Ingelheim GmbH Corporation Information
Table 83. Boehringer Ingelheim GmbH Description and Major Businesses
Table 84. Boehringer Ingelheim GmbH Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Boehringer Ingelheim GmbH Product
Table 86. Boehringer Ingelheim GmbH Recent Development
Table 87. Etubics Corp Corporation Information
Table 88. Etubics Corp Description and Major Businesses
Table 89. Etubics Corp Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Etubics Corp Product
Table 91. Etubics Corp Recent Development
Table 92. GeoVax Labs Inc Corporation Information
Table 93. GeoVax Labs Inc Description and Major Businesses
Table 94. GeoVax Labs Inc Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. GeoVax Labs Inc Product
Table 96. GeoVax Labs Inc Recent Development
Table 97. Merck KGaA Corporation Information
Table 98. Merck KGaA Description and Major Businesses
Table 99. Merck KGaA Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Merck KGaA Product
Table 101. Merck KGaA Recent Development
Table 102. Minerva Biotechnologies Corp Corporation Information
Table 103. Minerva Biotechnologies Corp Description and Major Businesses
Table 104. Minerva Biotechnologies Corp Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Minerva Biotechnologies Corp Product
Table 106. Minerva Biotechnologies Corp Recent Development
Table 107. Transgene SA Corporation Information
Table 108. Transgene SA Description and Major Businesses
Table 109. Transgene SA Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Transgene SA Product
Table 111. Transgene SA Recent Development
Table 112. Vaxil Bio Therapeutics Ltd Corporation Information
Table 113. Vaxil Bio Therapeutics Ltd Description and Major Businesses
Table 114. Vaxil Bio Therapeutics Ltd Mucin 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Vaxil Bio Therapeutics Ltd Product
Table 116. Vaxil Bio Therapeutics Ltd Recent Development
Table 117. Global Mucin 1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Mucin 1 Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Mucin 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Mucin 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Mucin 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Mucin 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Mucin 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Mucin 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Mucin 1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Mucin 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Mucin 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Mucin 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Mucin 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Mucin 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Mucin 1 Players
Table 135. Mucin 1 Customers List
Table 136. Mucin 1 Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Mucin 1 Product Picture
Figure 2. Global Mucin 1 Sales Market Share by Type in 2020 & 2026
Figure 3. TG-4010 Product Picture
Figure 4. GO-2032c Product Picture
Figure 5. ImMucin Product Picture
Figure 6. BI-1361849 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Mucin 1 Sales Market Share by Application in 2020 & 2026
Figure 9. Prostate Cancer
Figure 10. Breast Cancer
Figure 11. Colon Cancer
Figure 12. Ovarian Cancer
Figure 13. Others
Figure 14. Mucin 1 Report Years Considered
Figure 15. Global Mucin 1 Market Size 2015-2026 (US$ Million)
Figure 16. Global Mucin 1 Sales 2015-2026 (K Pcs)
Figure 17. Global Mucin 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Mucin 1 Sales Market Share by Region (2015-2020)
Figure 19. Global Mucin 1 Sales Market Share by Region in 2019
Figure 20. Global Mucin 1 Revenue Market Share by Region (2015-2020)
Figure 21. Global Mucin 1 Revenue Market Share by Region in 2019
Figure 22. Global Mucin 1 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Mucin 1 Revenue in 2019
Figure 24. Mucin 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Mucin 1 Sales Market Share by Type (2015-2020)
Figure 26. Global Mucin 1 Sales Market Share by Type in 2019
Figure 27. Global Mucin 1 Revenue Market Share by Type (2015-2020)
Figure 28. Global Mucin 1 Revenue Market Share by Type in 2019
Figure 29. Global Mucin 1 Market Share by Price Range (2015-2020)
Figure 30. Global Mucin 1 Sales Market Share by Application (2015-2020)
Figure 31. Global Mucin 1 Sales Market Share by Application in 2019
Figure 32. Global Mucin 1 Revenue Market Share by Application (2015-2020)
Figure 33. Global Mucin 1 Revenue Market Share by Application in 2019
Figure 34. North America Mucin 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Mucin 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Mucin 1 Sales Market Share by Country in 2019
Figure 37. North America Mucin 1 Revenue Market Share by Country in 2019
Figure 38. U.S. Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Mucin 1 Market Share by Type in 2019
Figure 43. North America Mucin 1 Market Share by Application in 2019
Figure 44. Europe Mucin 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Mucin 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Mucin 1 Sales Market Share by Country in 2019
Figure 47. Europe Mucin 1 Revenue Market Share by Country in 2019
Figure 48. Germany Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Mucin 1 Market Share by Type in 2019
Figure 59. Europe Mucin 1 Market Share by Application in 2019
Figure 60. Asia Pacific Mucin 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Mucin 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Mucin 1 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Mucin 1 Revenue Market Share by Region in 2019
Figure 64. China Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Mucin 1 Market Share by Type in 2019
Figure 87. Asia Pacific Mucin 1 Market Share by Application in 2019
Figure 88. Latin America Mucin 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Mucin 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Mucin 1 Sales Market Share by Country in 2019
Figure 91. Latin America Mucin 1 Revenue Market Share by Country in 2019
Figure 92. Mexico Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Mucin 1 Market Share by Type in 2019
Figure 99. Latin America Mucin 1 Market Share by Application in 2019
Figure 100. Middle East and Africa Mucin 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Mucin 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Mucin 1 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Mucin 1 Revenue Market Share by Country in 2019
Figure 104. Turkey Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Mucin 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Mucin 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Mucin 1 Market Share by Type in 2019
Figure 111. Middle East and Africa Mucin 1 Market Share by Application in 2019
Figure 112. North America Mucin 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Mucin 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Mucin 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Mucin 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Mucin 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Mucin 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Mucin 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Mucin 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Mucin 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Mucin 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
結腸がんの世界市場（～2026年） Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps throug…- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…
- 卵巣がんの世界市場（～2026年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …